H-1B sponsorship profile: Shape Therapeutics Inc. Across U.S. Department of Labor LCA disclosures, Shape Therapeutics Inc filed 13 Labor Condition Applications covering 13 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (13 certified of 13 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Shape Therapeutics Inc’s H-1B petitions range from $61,000 at the low end to $145,000 at the high end, with a petition-weighted average of $95,000. That range reflects the mix of occupations the company sponsors, led by Associate Scientist (4 petitions at $82,000 avg), followed by Senior Associate Computational Biologist and Scientist, Downstream Development . H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Shape Therapeutics Inc is headquartered in Seattle, WA under NAICS code 5417, and places H-1B workers across 1 state, most heavily in WA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Shape Therapeutics Inc ranks. By H-1B petition volume, Shape Therapeutics Inc is #13,807 of 119,880 employers nationally and #261 of 2,468 employers headquartered in WA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.